ATP6V0D2, a subunit associated with proton transport, serves an oncogenic role in esophagus cancer and is correlated with epithelial–mesenchymal transition
Sign Up to like & getrecommendations! Published in 2020 at "Esophagus"
DOI: 10.1007/s10388-020-00735-8
Abstract: Background The poor prognosis of esophagus cancer (EC) is mainly due to its high invasiveness and metastasis, so it is urgent to search effectively prognostic markers and explore their roles in the mechanism of metastasis.… read more here.
Keywords: mesenchymal transition; atp6v0d2; esophagus cancer; epithelial mesenchymal ... See more keywords
Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis
Sign Up to like & getrecommendations! Published in 2022 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001284
Abstract: More and more studies have focused on the regulatory role of circular RNAs (circRNAs) in various cancers. However, it is not clear how dexmedetomidine (DEX) affects esophagus cancer progression by affecting the expression of circRNAs.… read more here.
Keywords: dex; hmga2; circ 0003340; esophagus cancer ... See more keywords
Hsa_circ_0007380 silencing restrains the growth and enhances radiosensitivity in esophagus cancer by miR-644a/Spindlin 1 axis
Sign Up to like & getrecommendations! Published in 2022 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000001375
Abstract: Circular RNAs are frequently dysregulated and show important regulatory function of tumorigenesis in cancers. Hsa_circ_0007380 was found to be elevated in human radioresistant esophageal cancer cells. Here, this study aimed to investigate the action and… read more here.
Keywords: hsa circ; mir 644a; circ 0007380; esophagus cancer ... See more keywords
Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m6A Regulators
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/5490461
Abstract: Background Esophagus cancer (ESCA) is the sixth most frequent cancer in males, with 5-year overall survival of 15%–25%. RNA modifications function critically in cancer progression, and m6A regulators are associated with ESCA prognosis. This study… read more here.
Keywords: molecular subtypes; m6a regulators; esophagus cancer; cancer ... See more keywords
Transcription Activation of Rab8A by PEA3 Augments Progression of Esophagus Cancer by Activating the Wnt/β-Catenin Signaling Pathway
Sign Up to like & getrecommendations! Published in 2023 at "Disease Markers"
DOI: 10.1155/2023/8143581
Abstract: Background Rab8A has been reported as an oncogenic gene in breast and cervical cancer. However, the function and molecular mechanism of Rab8A in esophagus cancer has not been reported. Methods Rab8A expression was detected by… read more here.
Keywords: cancer cells; wnt catenin; rab8a; catenin signaling ... See more keywords
Magnolol inhibits growth and induces apoptosis in esophagus cancer KYSE-150 cell lines via the MAP kinase pathway.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of thoracic disease"
DOI: 10.21037/jtd.2019.07.46
Abstract: Background Magnolol has shown anti-cancer activity against a variety of cancers, such as liver, breast, lung and colon cancer. However, the role of magnolol in esophagus cancer cells is unknown. Methods In this study, esophagus… read more here.
Keywords: cancer; cell; esophagus cancer; magnolol ... See more keywords
Evaluation of dose calculations with inhomogeneity correction in intensity-modulated radiation therapy for esophagus cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of X-ray science and technology"
DOI: 10.3233/xst-17364
Abstract: BACKGROUND Differences often exist in the dose calculation accuracy caused by using different dose calculation algorithms in non-uniform tissues. OBJECTIVE To evaluate the accuracy of dose calculation with inhomogeneity correction in intensity-modulated radiation therapy (IMRT)… read more here.
Keywords: esophagus cancer; dose calculations; inhomogeneity correction;
Eupafolin Suppresses Esophagus Cancer Growth by Targeting T-LAK Cell-Originated Protein Kinase
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2019.01248
Abstract: Eupafolin is the main bioactive component extracted from the traditional Chinese medicine Ay Tsao (Artemisia vulgaris L.), and its anti-tumor activity has had been studied in previous researches. T-LAK cell-originated protein kinase (TOPK) belongs to… read more here.
Keywords: esophagus cancer; eupafolin; lak cell; protein kinase ... See more keywords